Showing results (401-410 of 650) with videos related to
Sort By:
Pageof 65
Nature Cancer|February 5, 2022
MTSS1 suppresses mammary tumor-initiating cells by enhancing RBCK1-mediated p65 ubiquitinationMin Cong, Yuan Wang, Yang Yang, et al.Nature Cancer|February 5, 2022
Palbociclib demonstrates intracranial activity in progressive brain metastases harboring cyclin-dependent kinase pathway alterationsPriscilla K Brastianos, Albert E Kim, Nancy Wang, et al.Nature Cancer|February 5, 2022
The deubiquitinase USP25 supports colonic inflammation and bacterial infection and promotes colorectal cancerXiao-Meng Wang, Ci Yang, Yin Zhao, et al.Nature Cancer|February 5, 2022
Discovery through clinical sequencing in oncologyMark T A Donoghue, Alison M Schram, David M Hyman, et al.Nature Cancer|February 5, 2022
TNF-α-producing macrophages determine subtype identity and prognosis via AP1 enhancer reprogramming in pancreatic cancerMengyu Tu, Lukas Klein, Elisa Espinet, et al.Nature Cancer|February 5, 2022
The cancer-testis lncRNA lnc-CTHCC promotes hepatocellular carcinogenesis by binding hnRNP K and activating YAP1 transcriptionAnliang Xia, Wenwen Yuan, Qiang Wang, et al.Nature Cancer|February 5, 2022
Gradient of Developmental and Injury Response transcriptional states defines functional vulnerabilities underpinning glioblastoma heterogeneityLaura M Richards, Owen K N Whitley, Graham MacLeod, et al.Nature Cancer|February 5, 2022
LXRα activation and Raf inhibition trigger lethal lipotoxicity in liver cancerRamona Rudalska, Jule Harbig, Marteinn T Snaebjornsson, et al.Nature Cancer|April 15, 2022
An allosteric inhibitor against the therapy-resistant mutant forms of EGFR in non-small cell lung cancerCiric To, Tyler S Beyett, Jaebong Jang, et al.Nature Cancer|March 27, 2023
Specific regulation of BACH1 by the hotspot mutant p53R175H reveals a distinct gain-of-function mechanismZhenyi Su, Ning Kon, Jingjie Yi, et al.Pageof 65